These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37693156)

  • 1. Adding nutritional status to the original BCLC stage improves mortality prediction for hepatocellular carcinoma patients in HBV-endemic regions.
    Lin YT; Lin PT; Lin CC; Wu TH; Liu LT; Su CW; Teng W; Tsai CY; Huang CH; Chen WT; Chan KM; Hsu CW; Lin CY; Lin SM; Chien RN
    Am J Cancer Res; 2023; 13(8):3618-3628. PubMed ID: 37693156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
    Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
    Chan AW; Kumada T; Toyoda H; Tada T; Chong CC; Mo FK; Yeo W; Johnson PJ; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1300-6. PubMed ID: 26751608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appraisal of a newly developed ALBI-sarcopenia score as a prognostic marker in patients with hepatocellular carcinoma.
    Elsabaawy M; Badran H; Ragab A; Abdelwahab R; Sayed E; Afify S; Othman W
    Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):924-928. PubMed ID: 38625821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
    Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
    Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
    Zhang ZQ; Xiong L; Zhou JJ; Miao XY; Li QL; Wen Y; Zou H
    World J Surg Oncol; 2018 Oct; 16(1):208. PubMed ID: 30326907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a predictive model for acute liver failure after hepatectomy based on neutrophil-to-lymphocyte ratio and albumin-bilirubin score.
    Li XP; Bao ZT; Wang L; Zhang CY; Yang W
    World J Gastrointest Surg; 2024 Apr; 16(4):1087-1096. PubMed ID: 38690037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
    J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study.
    Liu X; Qiu Z; Ndhlovu E; Wan Y; Sun H; Wang S; Cao Y; Zhu P
    J Hepatocell Carcinoma; 2024; 11():1127-1141. PubMed ID: 38895590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Lei HJ; Huang YH; Ko CC; Su CW; Lee RC; Hou MC; Huo TI
    Liver Int; 2020 Jan; 40(1):205-214. PubMed ID: 31505104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma.
    He C; Yang J; Jin Z; Zhu Y; Hu W; Zeng L; Li X
    Evid Based Complement Alternat Med; 2022; 2022():1801230. PubMed ID: 35845571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
    Pinato DJ; Sharma R; Allara E; Yen C; Arizumi T; Kubota K; Bettinger D; Jang JW; Smirne C; Kim YW; Kudo M; Howell J; Ramaswami R; Burlone ME; Guerra V; Thimme R; Ishizuka M; Stebbing J; Pirisi M; Carr BI
    J Hepatol; 2017 Feb; 66(2):338-346. PubMed ID: 27677714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade.
    Fang KC; Kao WY; Su CW; Chen PC; Lee PC; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
    Liver Cancer; 2018 Oct; 7(4):335-358. PubMed ID: 30488023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of The Hong Kong Liver Cancer Staging System in Patients with Hepatocellular Carcinoma after Curative Intent Treatment.
    Chuncharunee A; Siramolpiwat S
    Asian Pac J Cancer Prev; 2017 Jun; 18(6):1697-1701. PubMed ID: 28670891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study.
    Fujita K; Nomura T; Morishita A; Oura K; Yoneyama H; Kobara H; Tsutsui K; Himoto T; Masaki T
    Am J Trop Med Hyg; 2019 Jul; 101(1):220-225. PubMed ID: 31115300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
    Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
    World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.